Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

July 06, 2016 | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1. Xconomy